Reduced cGMP signaling activates NF-κB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A

Biochemical and Biophysical Research Communications

Volumn 327, Issue 1, 2005, Pages 106-111

  Vellaichamy, Elangovan ^a   Sommana, Naveen K ^a   Pandey, Kailash N ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac hypertrophy; cGMP signaling; Gene knockout; I B kinase; Natriuretic peptide receptor A; NF B

Indexed keywords

ATRIAL NATRIURETIC FACTOR RECEPTOR; CYCLIC GMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CYCLIC GMP; GUANYLATE CYCLASE; I-KAPPA B PROTEINS; MICE; MICE, KNOCKOUT; NF-KAPPA B; PHOSPHORYLATION; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION;

EID: 11144225487     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.11.153     Document Type: Article

References (27)

1. A.J. de Bold Atrial natriuretic factor: a hormone produced by the heart Science 230 1985 767 770
2. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N. Engl. J. Med. 339 1998 321 328
3. D.L. Garbers Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands Cell 71 1992 1 4
4. J.G. Drewett, and D.L. Garbers The family of guanylyl cyclase receptors and their ligands Endocr. Rev. 15 1994 135 162
5. K.N. Pandey, S.N. Pavlou, and T. Inagami Identification and characterization of three distinct atrial natriuretic factor receptors. Evidence for tissue-specific heterogeneity of receptor subtypes in vascular smooth muscle, kidney tubular epithelium, and Leydig tumor cells by ligand binding, photoaffinity labeling, and tryptic proteolysis J. Biol. Chem. 263 1988 13406 13413
6. K.N. Pandey Intracellular trafficking and metabolic turnover of ligand-bound guanylyl cyclase/atrial natriuretic peptide receptor-A into subcellular compartments Mol. Cell. Biochem. 230 2002 61 72
7. A. Calderone, C.M. Thaik, N. Takahashi, D.L. Chang, and W.S. Colucci Nitric oxide, atrial natriuretic peptide, and cyclic-GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts J. Clin. Invest. 101 1998 812 818
8. L. Cao, and D.G. Gardner Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts Hypertension 25 1995 227 234
9. K.N. Pandey, H.T. Nguyen, M. Li, and J.W. Boyle Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase Biochem. Biophys. Res. Commun. 271 2000 374 379
10. G.D. Sharma, H.T. Nguyen, A.S. Antonov, R.G. Gerrity, T. von Geldern, and K.N. Pandey Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells Mol. Cell. Biochem. 233 2002 165 173
11. P.M. Oliver, J.E. Fox, R. Kim, H.A. Rockman, H.S. Kim, R.L. Reddick, K.N. Pandey, S.L. Milgram, O. Smithies, and N. Maeda Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Proc. Natl. Acad. Sci. USA 94 1997 14730 14735
12. I. Kishimoto, K. Rossi, and D.L. Garbers A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy Proc. Natl. Acad. Sci. USA 98 2001 2703 2706
13. A. Zahabi, S. Picard, N. Fortin, T.L. Reudelhuber, and C.F. Deschepper Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts J. Biol. Chem. 278 2003 47694 47699
14. A.S. Baldwin Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights Annu. Rev. Immunol. 14 1996 649 683
15. N.H. Purcell, G. Tang, C. Yu, F. Mercurio, J.A. DiDonato, and A. Lin Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes Proc. Natl. Acad. Sci. USA 98 2001 6668 6673
16. Y. Li, T. Ha, X. Gao, J. Kelley, D.L. Williams, I.W. Browder, R.L. Kao, and C. Li NF-kappa B activation is required for the development of cardiac hypertrophy in vivo Am. J. Physiol. Heart. Circ. Physiol. 287 2004 H1712 H1720
17. A.R. Brasier, M. Jamaluddin, Y. Han, C. Patterson, and M.S. Runge Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappa B (NF-kappa B) transcription factor Mol. Cell. Biochem. 212 2000 155 169
18. P. Rouet-Benzineb, B. Gontero, P. Dreyfus, and C. Lafuma Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway J. Mol. Cell. Cardiol. 32 2000 1767 1778
19. C. Li, W. Browder, and R.L. Kao Early activation of transcription factor NF-kappa B during ischemia in perfused rat heart Am. J. Physiol. 276 1999 H543 H552
20. J.D. Dignam, R.M. Lebovitz, and R.G. Roeder Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei Nucleic Acids Res. 11 1983 1475 1489
21. C.L. Dent, M.D. Smith, and D.S. Latchman Transcription factors: A Practical Approach 1999 Oxford University Press London, UK pp. 1-25
22. F. Mercurio, B.W. Murray, A. Shevchenko, B.L. Bennett, D.B. Young, J.W. Li, G. Pascual, A. Motiwala, H. Zhu, M. Mann, and A.M. Manning Ikappa B kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex Mol. Cell. Biol. 19 1999 1526 1538
23. D.M. Rothwarf, E. Zandi, G. Natoli, and M. Karin IKK-gamma is an essential regulatory subunit of the Ikappa B kinase complex Nature 395 1998 297 300
24. S. Frantz, D. Fraccarollo, H. Wagner, T.M. Behr, P. Jung, C.E. Angermann, G. Ertl, and J. Bauersachs Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure Cardiovasc. Res. 57 2003 749 756
25. C.D. Collard, A. Agah, W. Reenstra, J. Buras, and G.L. Stahl Endothelial nuclear factor-kappa B translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues Arterioscler. Thromb. Vasc. Biol. 9 1999 2623 2629
26. R.H. Ritchie, R.J. Schiebinger, M.C. LaPointe, and J.D. Marsh Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide Am. J. Physiol. 275 1998 H1370 H1374
27. S. Kaul, B. Cercek, J. Rengstrom, X.P. Xu, M.D. Molloy, P. Dimayuga, A.K. Parikh, M.C. Fishbein, J. Nilsson, T.B. Rajavashisth, and P.K. Shah Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappa B J. Am. Coll. Cardiol. 35 2000 493 501